Marcela Maus
Hematology & Oncology · Philadelphia, PANPI 1639233877
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $105,119 of the $111,321 with a category attached, or 94.4%. 14 manufacturers reported payments, led by GSK at 29.0% of the total. Among hematology & oncology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $1590.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$32K
- E.r. Squibb & Sons, L.L.C.$17K
- Gilead$14K
- Novartis$9K
- Chugai Pharmaceutical Co., Ltd.$9K
- AstraZeneca$7K
- plus $23K from 8 others
Across 69 payments — averaging $62,102 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$3.9M
- Modernatx, Inc.$254K
- Institut DE Recherches Internationales Servier$109K
- Bristol Myers Squibb$3K
- Servier Bioinnovation$2K
What the payments were for
- Consulting fees$105,11994%
- Travel & lodging$4,9664%
- Food & beverage$1,1411%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 16 | $32,252 |
| E.r. Squibb & Sons, L.L.C. | 3 | $16,851 |
| Gilead(2 entities) | 7 | $14,110 |
| Novartis | 7 | $9,160 |
| Chugai Pharmaceutical Co., Ltd. | 7 | $8,606 |
| AstraZeneca(2 entities) | 5 | $6,921 |
| EMD Serono, Inc. | 1 | $6,750 |
| Sanofi US Services Inc. | 1 | $4,374 |
| Sobi, Inc | 10 | $3,700 |
| Regeneron | 6 | $3,550 |
| Bayer | 4 | $3,175 |
| Biontech SE | 1 | $1,000 |
| Bristol Myers Squibb | 1 | $750 |
| Merck | 1 | $123 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYMRIAH$8,954
- Yescarta$7,000
- Gamifant$3,338
- Non-Covered$3,175
How this compares
$111,321 in reported general payments places this provider in the 95th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Philadelphia
- Henry FungPhiladelphia$730K
- Charu AggarwalPhiladelphia$541K
- Corey LangerPhiladelphia$492K
- Ankur ParikhPhiladelphia$329K
- Catherine LaiPhiladelphia$281K
- Stephen SchusterPhiladelphia$218K
- Keith PratzPhiladelphia$173K
- David PorterPhiladelphia$140K
- Adam BinderPhiladelphia$136K
- Pierluigi PorcuPhiladelphia$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.